The global HIV diagnostics market is entering a pivotal transition phase. Valued at USD 2,600.09 million in 2024, this market is projected to reach USD 2,791.20 million by 2025 and surge to USD 5,396.32 million by 2034, reflecting a compound annual growth rate (CAGR) of 7.6 % during 2025–2034. In this timeframe, regional heterogeneity will strongly shape competitive advantage,...